Bio-Rad Laboratories, Inc. logo BIO - Bio-Rad Laboratories, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 7
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $321.67 DETAILS
HIGH: $335.00
LOW: $310.00
MEDIAN: $320.00
CONSENSUS: $321.67
UPSIDE: 8.63%

About Bio-Rad Laboratories, Inc. (https://www.bio-rad.com)

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Key Executives

NAME TITLE DOB SALARY
Norman D. Schwartz Chairman & Chief Executive Officer 1950 $1,680,292 USD
Jonathan DiVincenzo President & Chief Operating Officer 1966 $1,172,954 USD
James J. Barry Executive Vice President & President of Life Science Group 1978 $1,106,516 USD
Roop K. Lakkaraju Executive Vice President & Chief Financial Officer 1971 $984,424 USD
Michael Crowley Executive Vice President of Global Commercial Operations 1962 $649,798 USD
Rajat Mehta Executive Vice President of Global Commercial Operations 1979 $649,798 USD
Courtney C. Enloe Executive Vice President, General Counsel & Secretary 1972
Matthew Werner Senior Vice President and Chief Compliance & Privacy Officer
Nanditha R. Yelamanchi Executive Vice President of Global Human Resources
Ruben Argueta Vice President of Investor Relations

Company Peers

Peer analysis pending, check back in 1-2 minutes.